8-K
Current Report
NextCure, Inc. Filed Acc 0001104659-26-083326
Material agreement · Exit or restructuring costs · Change in control · Executive or director change · Regulation FD disclosure · Other events
- Item 1.01 Entry into a material definitive agreement
- Item 2.05 Costs associated with exit or disposal activities
- Item 5.01 Changes in control of the registrant
- Item 5.02 Departure or appointment of directors or officers
- Item 7.01 Regulation FD disclosure
- Item 8.01 Other events
From the SEC's structured data for this filing
Loading tm2620428d1_8k.htm…